Cone Beam CT Scanning in Lung and Bladder Cancer.

Completed

• Conditions: Bladder Carcinoma; Lung Neoplasm; Small Cell Carcinoma

• Registration Number: NCT00469066
• Lead Sponsor: AHS Cancer Control Alberta

Brief Summary

To study changes in tumor and normal organ size and/or position which occur during a course of radiation treatments.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-05
• Study First Submitted: 2007-05-02
• Study First Submitted QC: 2007-05-02
• Study First Posted: 2007-05-04
• Primary Completion: 2009-08
• Study Completion: 2010-04
• Status Verified: 2011-12
• Last Update Submitted: 2016-02-23
• Last Update Posted: 2016-02-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

• Patient has biopsy proven limited stage SCLC
• receiving radical concurrent chemoradiotherapy
• no prior chest RT
• no prior surgical resection of lung tumor
• no prior chemotherapy
• patients' lung tumors should be centrally-located to minimize the effect of respiratory motion
• patient has biopsy proven TCC bladder
• receiving radical concurrent chemoradiotherapy or RT alone
• no prior chemotherapy
• patient signs study-specific consent form

Exclusion Criteria

• mixed small cell and non small cell histology
• patient not being treated with concurrent chemoradiotherapy
• chemoradiotherapy given sequentially
• previous chest RT
• previous chemotherapy
• prior surgical resection of lung mass
• patient ineligible for pelvic RT
• patient does not sign study consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Cross Cancer Institute; 🇨🇦 Edmonton, Alberta, Canada